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Abstract: 
We have developed a system for producing a supramolecular scaffold that permeates the 
entire Escherichia coli cytoplasm. This cytoscaffold is constructed from a three-component 
system comprising a bacterial microcompartment shell protein and two complementary de 
novo coiled-coil peptides. We show that other proteins can be targeted to this intracellular 
filamentous arrangement. Specifically, the enzymes pyruvate decarboxylase and alcohol 
dehydrogenase have been directed to the filaments leading to enhanced ethanol production 
in these engineered bacterial cells compared with those that do not produce the scaffold.  
This is consistent with improved metabolic efficiency through enzyme colocation.  Finally, 
the shell-protein scaffold can be directed to the inner membrane of the cell, demonstrating 
how synthetic cellular organization can be coupled with spatial optimization through in-cell 
protein design. The cytoscaffold has potential for the development of next-generation cell 
factories, where it could be used to organize enzyme pathways and metabolite transporters 
to enhance metabolic flux. 
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Introduction: 
In industrial biotechnology and synthetic biology there is a growing need to generate internal 
bacterial supramolecular scaffolds en route to delivering so-called cell factories1. To this end, 
researchers have investigated protein-based linkers2, lipids3 and nucleic acids4,5 as 
modulators to attain high-level biomolecular organization. However, none of these 
approaches have delivered a uniform matrix throughout a bacterial cytoplasm. The 
advantage of such scaffolding systems is that they can be used to direct and align 
biosynthetic pathway enzymes to orchestrate greater production of commodity and speciality 
chemicals, especially in pathways that proceed through unstable or toxic intermediates6,7. 
This is because the close proximity of enzymes on a scaffold allow for greater channeling of 
intermediates, through improved flux, stabilization of intermediates and protection from other 
reactions8,9. 
A number of natural scaffolds are found in bacterial cells. For instance, bacterial 
microcompartments (BMCs) are organelles with an outer semi-permeable scaffold in the 
form of a protein shell, which encases a specific metabolic pathway10-12.  BMCs have a 
diameter of ≈150 nm and possess high concentrations of internalized enzymes. This is most 
apparent in carboxysomes, which are anabolic BMCs, where the high concentrations of 
carbonic anhydrase and RuBisCO ensure enhanced carbon fixation13,14. In catabolic BMCs, 
such as the metabolosome associated with propanediol utilization (the so-called Pdu 
system), internalized enzymes necessitate that propionaldehyde is rapidly transformed into 
either an alcohol or a CoA thioester, thereby protecting the cell from the potentially toxic 
aldehyde intermediate15-17. In all cases, the enzymes are targeted to the interior of the BMCs 
by small encapsulation peptides, which interact with a component of the outer shell 
scaffold18-21. Modelling studies indicate that BMCs enhance flux through intermediate 
sequestration22. Recently, a detailed structure of a recombinant BMC shell has been 
reported, showing the precise orientation of the different shell proteins that tile together to 
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form the outer casing, providing molecular detail on how the shell proteins scaffold together 
to act as a semi-permeable membrane23. 
Apart from BMCs, the other major scaffold within prokaryotic cells is the cytoskeleton24, 
which is generally distributed around the inner membrane. This filamentous structure has 
roles in cell division, cell morphology and structural polarity.  Components of the bacterial 
cytoskeleton include proteins such as FtsZ, MreB, ParM and MinD25,26. However, the 
essential nature of these proteins precludes them from being developed as major cellular 
matrices. For these reasons, we sought to construct a simple and modular bacterial 
cytoskeleton, which we call a cytoscaffold, from components that we understand and can 
manipulate predictably. 
Previously, we had shown that a single shell protein from the Citrobacter freundii 
propanediol utlisation (Pdu) BMC, with a minor modification to its C terminus to improve 
solubility (PduA*), forms filaments in E. coli27. PduA itself hexamerizes to form a tile that 
assembles to make the facets of the BMC casing28,29. However, when overproduced 
recombinantly in E. coli, PduA* forms hollow filaments ≈ 20 nm in diameter that span the 
length of the cell30. Moreover, these structures often interfere with septation during cell 
division. Nonetheless, we reasoned that PduA*-based filamentous structures could present 
tractable scaffolds for tethering other proteins.  
Here, we describe a three-component system comprising PduA and two complementary de 
novo designed coiled-coil peptides31, that form an interactive intracellular filamentous 
arrangement that gives the appearance of a matrix that permeates the entire E. 
coli cytoplasm (Supplementary Fig. 1). We show that other proteins can be specifically 
targeted to these cytoscaffolds.  Building on this, we demonstrate that tethering metabolic 
enzymes for ethanol production to the PduA scaffold increases their effective local and 
relative concentrations, and results in improved ethanol production. Finally, we show that the 
scaffold can be directed to the inner membrane of the cell further illustrating its modularity, 
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flexibility, and utility and demonstrates how synthetic cellular organization can be coupled 
with spatial optimization. 
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Results: 
Construction of a filamentous scaffold. Initially, we tested if different proteins could be 
recruited to PduA* filaments in vivo in an analogous way to how encapsulation peptides are 
thought to work in natural BMCs (vide supra). Attempts to use the natural encapsulation 
peptides themselves were not very successful mainly due to aggregation within the cell32. 
Therefore, we turned to a better-characterized de novo designed heterodimeric coiled-coil 
system, CC-Di-AB31, which has been used successfully to construct self-assembling peptide 
cages33. The heterodimer comprises two peptides (acidic (A) and basic (B)) that do not self-
associate, but do interact specifically and tightly when mixed. The concept was to fuse either 
CC-Di-A or CC-Di-B to PduA*, and then test if a reporter protein with the cognate peptide 
could be targeted to the filaments. Plasmids encoding fusion proteins of the following type 
were made: CC-Di-A/B—Gly/SerLinker—HexaHisTag—PduA*, referred to as CC-Di-A—
PduA* and CC-Di-B—PduA*. A control plasmid harboring the fusion without the CC-Di-A/B 
module, i.e. containing only the Gly/SerLinker—HexaHisTag (C—PduA*), was also made. 
Plasmids were transformed individually into E. coli cells and the resulting strains were 
grown, induced and analyzed by transmission electron microscopy (TEM) after fixation, 
embedding, thin sectioning and staining. 
Strains expressing PduA* alone generated parallel filaments spanning the length of the cell 
(Fig. 1a), and appear to interfere with septation (Supplementary Fig. 2). Unexpectedly, the 
strains producing the control C—PduA* and the CC-Di-A—PduA* did not form any 
filamentous structures (Fig. 1b  and Supplementary Fig. 3). C—PduA* gave deposits of 
material at the poles of the cell suggesting that the Gly/Ser linker and/or the hexa-histidine 
tag alone affects solubility of the fusion protein. This was not seen with CC-Di-A—PduA*, but 
it is not clear why filaments do not form with this construct. In both cases, western blots 
revealed only low levels of CC-Di-A—PduA* and C—PduA* fusions in comparison to 
untagged PduA*, suggesting a potential cytotoxicity of these proteins (Supplementary Fig. 
4). In contrast, large amounts of CC-Di-B—PduA* were detected in the cells transformed 
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with its plasmid (Supplementary Fig. 4), and this led to numerous filaments throughout the 
cytoplasm (Fig. 1c and Supplementary Fig. 5). These filaments had a similar 23.6 ± 2.78 
nm (n = 100) diameter to untagged PduA* filaments30, but the former were considerably 
shorter (Fig. 1d and e). Consequently, CC-Di-B—PduA* filaments were not aligned within 
cells, and they did not appear to disrupt cells. It is not clear why the CC-Di-B—PduA* 
filaments are shortened, but possibly the highly charged CC-Di-B peptide limits filament 
growth in some way.  
Characterisation of the cytoscaffold. To probe the spatial localization and organization of 
the shorter CC-Di-B—PduA* filaments, thicker thin sections (250 nm) were cut and prepared 
for TEM tomography. Analysis of the resulting tomogram confirmed the presence of the 
shorter filaments throughout the cytoplasm, except in a central region that is largely 
occupied by genomic DNA (Fig. 1f). Using methods developed to track microtubule 
assemblies in cells34, these structures were rendered and visualized in three dimensions 
(Fig. 1f and Supplementary Videos 1 and 2). This made clear that the filaments were not 
aligned but arrayed with multiple orientations resulting in the appearance of an internal 
matrix. Analysis of these filaments revealed an average length of 161.2 ± 102.4 nm (n = 
739); although, due to the limitation of a 250 nm thin section, the true length is likely longer 
than this (Fig. 1e). 
To test the robustness of the CC-Di-B—PduA* filaments, and to interrogate their structure in 
more detail, the filaments were purified from cells using protocols developed for BMC 
isolation21. Cells were lysed and the filaments were purified by combining centrifugation and 
differential salt precipitation (Supplementary Fig. 6). Purified filaments were analyzed by 
TEM and AFM. Both confirmed intact filaments and these approaches provide the 
opportunity to gain greater insight into the molecular organization of these structures 
(Supplementary Fig. 7). These ex vivo filaments tended to cluster together on the TEM 
grids and AFM substrates. This clustering was also seen, though to a lesser extent, in some 
thin sections of whole cells visualized by TEM.  
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Targeting to and functionalization of the cytoscaffold. Next, we tested if the CC-Di-B 
peptides of the CC-Di-B—PduA* filaments were available for targeting by other proteins 
labelled with CC-Di-A using the fluorescent protein citrine. To do this, we made CC-Di-A—
citrine and C—citrine constructs similar in design to the fusion proteins described above. By 
cloning these constructs in compatible plasmids, they could either be transformed alone or 
co-transformed with the plasmid producing CC-Di-B—PduA*. 
On their own, both CC-Di-A—citrine and C—citrine gave uniform fluorescence throughout 
the cells, consistent with soluble, cytoplasmic proteins (Supplementary Fig. 8).  Similarly, 
when co-expressed with CC-Di-B—PduA*, the C—citrine control gave fluorescence 
distributed throughout the cell. In contrast, co-expression of CC-Di-A—citrine and CC-Di-B—
PduA* gave more punctate fluorescence, and reduced fluorescence around the genomic 
DNA (Fig. 2a). This is consistent with CC-Di-A—citrine being localized to the filamentous 
scaffold. Correlative Light Electron Microscopy (CLEM)35,36 of high-pressure frozen cells co-
expressing CC-Di-A—GFP and CC-Di-B—PduA* confirmed the localization of fluorescence 
to the intracellular filamentous network (Figs. 2b & c). Control strains expressing the CC-Di-
B-PduA* filaments with untagged GFP showed only a cytoplasmic signal (Supplementary 
Fig. 9). Expression of CC-Di-B-citrine +/- CC-Di-B-PduA* resulted in punctate fluorescence 
suggesting self-association of the CC-Di-B peptide (Supplementary Fig. 8). 
To demonstrate that multiple cargo proteins could be directed to the cytoscaffold, CC-Di-A—
citrine and a CC-Di-A—mCherry fusion were co-produced in cells with CC-Di-B—PduA* 
filaments. This gave similar patterns to those observed with CC-Di-A—citrine plus CC-Di-
B—PduA*, and the mCherry and citrine signals co-localized (Figs. 2d – f). 
Whilst the results clearly demonstrate that fluorescent protein can be localized to the PduA* 
filaments through the use of the coiled-coil interaction, we also wanted to investigate if 
enzymes could be pegged onto the PduA* filaments in a similar fashion.  To investigate this 
pyruvate decarboxylase (Pdc) and alcohol dehydrogenase (Adh) were both tagged with the 
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CC-Di-A peptide and co-expressed with and without the CC-Di-B-PduA* filaments. 
Intriguingly, strains expressing Pdc and Adh grow to a significantly higher OD600 in 
comparison to both control strains (Supplementary Fig. 10a). GC/MS analysis of the growth 
medium revealed that the introduction of the CC-Di-B-PduA* filamentous network increased 
ethanol production by 221% per OD unit (t = 120 hrs) in comparison to a strain expressing 
Pdc and Adh but not the cytoscaffold (Fig. 3 and Supplementary Fig. 10b). Western blot 
analysis showed that this increase in ethanol production was not due to increased protein 
expression: indeed, the levels of Pdc and Adh were actually reduced by 48 ± 13.3 % and 26 
± 5.5 %, respectively, in the strain expressing CC-Di-A tagged enzymes in the presence of 
the CC-Di-B-PduA* filaments (Supplementary Fig. 11). The presence of filaments in these 
strains was confirmed by TEM analysis (Supplementary Fig. 12). These experiments 
provide strong evidence that the localization of enzymes onto the PduA* scaffold 
significantly enhances an engineered metabolic pathway. 
As a final demonstration of the modularity, versatility and potential utility of the new 
cytoscaffold, we tested if it could be directed to the cytoplasmic side of the inner membrane 
of E. coli (Fig. 4). For this, we added the C-terminal membrane-localizing region of MinD 
from B. subtilis to the CC-Di-A—citrine fusion to render CC-Di-A—citrine—MinD37. When 
expressed in cells and imaged by confocal fluorescence microscopy, halos around the 
cytoplasm where evident indicating localization of the citrine to the cell membrane (Fig. 4b). 
This was also the case for the C—citrine—MinD control (Supplementary Fig. 13). When 
each of these were co-expressed with CC-Di-B—PduA* filaments we observed differences 
in location between control and membrane-targeting constructs (Fig. 4a).  
First, in cells expressing CC-Di-B—PduA* alone, an average 30% of the filaments were 
associated with the membrane. For CC-Di-B—PduA* plus the C—citrine—MinD control this 
localization was very similar (31%). In contrast, however, for the CC-Di-B—PduA* plus CC-
Di-A—citrine—MinD combination 60% of the filaments were localized to the inner 
membrane, this difference is statistically significant with p < 0.01. One-way ANOVA showed 
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no significant difference (p < 0.01) in the total number of filaments between the three strains. 
Collectively, these analyses demonstrate that the cellular spatial location of the CC-Di-B-
PduA* filaments can be controlled by interactions with the cognate de novo designed coiled-
coil pair. 
 
Discussion: 
Previously we and others have shown that individual shell proteins, which form the 
hexameric tiles of the BMC casing, generate long filamentous macromolecular structures 
when overproduced in the host bacterial cells30,38. These structures are particularly apparent 
with PduA* from the propanediol utlization BMC. The filaments formed by PduA* are ≈20 nm 
in diameter.  They can be several microns long and have a tendency to stack together and 
align along the length of the cell, to the extent that they interfere with cell septation. We 
hypothesized that the PduA* filaments could be formed from the self-association of the 
hexameric tiles into a protein sheet that then rolls into a nanotubule filament. We wondered if 
it would be possible to target specific proteins to these filaments to generate higher-order 
supramolecular organization the cell by design. 
To achieve this we have employed a heterodimeric coiled-coil system, CC-Di-A and CC-Di-
B31, previously characterized and used, for example, in the de novo construction of peptide 
cages33. We find that whilst fusion of the CC-Di-A sequence onto PduA* results in low 
protein production and loss of filament formation, the attachment of CC-Di-B to PduA* leads 
to the formation of much shorter filaments that are dispersed throughout the cytoplasm. The 
reason for the shorter filaments is not clear, but could be due to a slight frustration of 
hexamer packing when the positively charged CC-Di-B is appended, or from faster 
nucleation of CC-Di-B—PduA* fusions resulting in more shorter filaments. Significantly, 
given the quantity of filaments that are produced throughout the cell, their formation and 
presence does not appear to alter cell viability or growth. 
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By adding the complementary CC-Di-A peptide onto fluorescent proteins we show through 
imaging techniques that these tagged proteins can be recruited to the CC-Di-B—PduA* 
filaments, demonstrating that the filaments can act as molecular scaffold. A key 
biotechnological use of scaffolds within a cell would be to localize biosynthetic enzymes in 
close proximity to one another in order to facilitate metabolic channeling. This is part of the 
theory behind multi-enzyme complexes although in these cases direct transfer or channeling 
of metabolites from one enzyme to the next also takes place. Using simple systems it has 
been shown that compartmentalization of pyruvate decarboxylase and alcohol 
dehydrogenase within a recombinant BMC improves production of ethanol from pyruvate21. 
Similarly, the direct fusion of these two enzymes also results in improved flux39, indicating, in 
both cases, that having the second enzyme in close proximity to the first ensures that the 
unstable acetaldehyde intermediate is more efficiently converted into the alcohol. Therefore, 
we targeted pyruvate decarboxylase and alcohol dehydrogenase to the PduA filaments 
using the coiled-coil modules, and much more ethanol is produced in comparison to when 
the enzymes are expressed in the absence of the scaffold. This provides very strong 
evidence that the PduA scaffolds can be used to cluster metabolic enzymes in order to 
accelerate the channeling of intermediates from one enzyme to the next. 
The CC-Di-B peptide can also be used to control the localization of the PduA filaments 
within the cell. This was achieved by targeting the CC-Di-A-citrine protein to the inner 
membrane by fusing on the MinD membrane-targeting region to the C terminus of the 
construct. Co-expression of this CC-Di-A-citrine-MinD protein with CC-Di-B-PduA* directed 
filaments to the inner-membrane surface. Such localization strategies could be used to 
ensure that pathway-enriched filaments have ready access to metabolites that are taken up 
via transporters, or conversely to ensure that products are generated near the membrane for 
export out of the cell.  
Furthermore, the fact that the CC-Di-B-PduA* filaments are able to interact easily with either 
cytosolic proteins or membrane-targeted proteins containing the CC-Di-A peptide suggests 
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that the N-terminal region of PduA must be solvent exposed. The two sides of the hexameric 
PduA tiles are distinguished by their concave and convex appearance. The N terminus of 
PduA, to which the CC-Di-B is fused, is located on the concave side of the protein. The fact 
that this CC-Di-B peptide is available for interaction with a CC-Di-A-tagged protein strongly 
infers that the filament formed from PduA is generated with the concave side exposed to the 
solvent. This agrees with the recent structure of a recombinant BMC, where all the shell 
proteins were found to orientated with the concave side facing out of the structure23. 
Overall, this work presents and demonstrates a concept for performing and evaluating 
rational protein design in the cell.  Specifically, making hybrid scaffolds comprising de novo 
designed peptides and natural proteins, which can be engineered on the micron scale within 
the E. coli cytoplasm. Visualization of filaments with and without appended ancillary proteins, 
and of those broadly distributed filaments or those localized to the inner membrane, 
demonstrates the potential of the system as a universal scaffold for the attachment, 
dispersion or localization of targeted cargo throughout the cell. We believe that these 
features and properties of the cytoscaffold, coupled with its ease of decoration and 
remodelling within cells, will enable applications in biotechnology and synthetic biology. 
More generally, this ability to design and engineer proteins in the cell could usher in a new 
era of rational protein design and engineering in vivo.   
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Figure Legends 
 
Figure 1. Transmission electron micrographs and analysis of PduA*-based constructs 
and filaments in E. coli. (a) Untagged PduA* filaments. (b) CC-Di-A-PduA* (c) CC-Di-B—
PduA* filaments.  (d) 3D render of CC-Di-B—PduA* filaments in E. coli based on a 250 nm 
tomogram.  Also see movie S1. (e) Histogram showing lengths of CC-Di-B-PduA* filaments 
based on a 250 nm tomogram rendering shown in d n = 739. (f) Histogram showing the 
diameter of CC-Di-B-PduA* filaments n = 100. Scale bars in a, b and c show 200 nm.  
 
Figure 2. Localization of fluorescent proteins to a bacterial cytoscaffold. (a) Co-
expression of CC-Di-B-PduA* with CC-Di-A-Citrine.  (b) TEM, (d) fluorescence, 
(f) overlay, (h) zoom in; Correlative Light Electron Microscopy of a strain expressing CC-Di-
B—PduA* and CC-Di-A—GFP. (c) Citrine, (e) mCherry and (g) overlay fluorescence signals 
of cells expressing CC-Di-B—PduA* and CC-Di-A—citrine and CC-Di-A—mCherry. Scale 
bars show 5 µm unless otherwise indicated. 
 
Figure 3. In vivo ethanol production. Graph shows ethanol content of the growth medium 
over time normalized to an OD600 = 1. E. coli strain transformed with empty plasmids 
(pET14b and pLysS) (), strain producing CC-Di-B-PduA* only (), strain producing CC-Di-
A-Pdc and CC-Di-A-Adh (r), strain producing CC-Di-A-Pdc, CC-Di-A-Adh and CC-Di-B-
PduA* (p). Data points represent an average of three independent experiments; standard 
deviations are represented by error bars. 
 
Figure 4. Targeting the bacterial cytoscaffold to the inner membrane of E. coli. (a) Box-
and-whisker plots showing the number of filaments associated with the inner membrane for 
3 strains expressing variants of the CC-Di-A/B—PduA* system. Plot 1 = CC-Di-B-PduA*, 
Plot 2 = CC-Di-B-PduA* + CC-Di-A-citrine-MinD, Plot 3 = CC-Di-B-PduA* + CC-Di-C-citrine-
MinD. Boxes show first and third quartiles, solid line shows median, dotted lines give the 
mean and whiskers the minimum and maximum; 250 cells were analyzed for each of the 3 
strains. Statistically significant differences (p=0.01) are indicated by **.  (b) Confocal image 
of strain expressing CC-Di-A—citrine—MinD scale bar is 5 µm.  (c) TEM micrograph of 
strains producing CC-Di-B—PduA* plus CC-Di-A—citrine—MinD, arrows indicate transverse 
filaments. Zoom in of area 1 in panels c (d). 
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Online Methods: 
Cloning of coiled-coil fused constructs. DNA encoding CC-Di-A and CC-Di-B embedded 
within a GS linker followed by a hexahistidine tag and a thrombin cleavage sequence was 
synthesized and cloned into the XbaI/ NdeI sites of pET14b. A control sequence containing 
only a GS linker, hexahistidine tag and thrombin cleavage sequence was also synthesized 
and cloned by the same strategy. Synthesized DNA sequences and amino acid sequences 
are shown in Supplementary Table 2. 
Expression of coiled coil constructs. E. coli BL21 * (DE3) competent cells were 
transformed with a plasmid (s) containing the gene(s) of interest, and plated onto LB agar 
plates supplemented with appropriate antibiotics (ampicillin 100 mg/L and/ or 
chloramphenicol 34 mg/L).  For TEM analysis 50 mL of LB was inoculated 1:100 from an 
overnight starter culture and grown at 37 °C with shaking to an OD600 of ~ 0.4, protein 
production was induced by the addition of IPTG to a final concentration of 400 µM, cultures 
were subsequently incubated overnight at 19 °C with shaking. For time course analysis 500 
mL of LB was inoculated, grown and induced as described previously. At time intervals 50 
mL of media was removed for TEM analysis. For purification of nanotubes 250 mL LB was 
inoculated 1:100 from an overnight starter culture and grown 37 °C to an OD600 ~ 0.4. 
Protein production was induced by addition of IPTG to a final concentration of 400 µM, 
cultures were then incubated with shaking at 19 °C overnight. For confocal imaging 
experiments 50 mL of LB was inoculated 1:100 from an overnight starter culture and grown 
with shaking at 37 °C to an OD600 ~ 0.4. protein production was induced by addition of IPTG 
to a final concentration of 400 µM, cultures were then incubated with shaking at 19 °C for 4 
hours. 
In vivo ethanol production. For in-vivo ethanol production, 100 mL of LB supplemented 
with 4% glucose and appropriate antibiotics was inoculated from overnight starter cultures to 
a starting OD600 of 0.05; cultures were grown at 28 °C for 120 hours with shaking at 150 rpm. 
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Protein production was induced by addition of IPTG to a final concentration of 400 µM after 4 
hours of growth. During growth, 1 mL samples were removed at 0, 2, 4, 6, 12, 24, 48, 72, 96 
and 120 hours for GC/MS analysis of the growth medium. Samples (1 mL) were also taken 
at each time point for SDS-PAGE analysis. Additional samples (5 mL) were taken after 24 
hours for TEM analysis. 
Western blot analysis. Nitrocellulose membranes following transfer and blocking were 
incubated in primary antibody (rabbit anti-PduA 1 μg/ mL or mouse anti-His (Sigma Aldrich) 
1:3000) followed by incubation in a secondary antibody coupled to alkaline phosphatase 
(Goat Anti-Rabbit IgG (H+L) Alkaline Phosphatase Conjugate (Bio-Rad) 1:3000 or Anti-
Mouse IgG (H+L), AP Conjugate (Promega) 1:5000). Bands were visualized by incubation in 
substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT). 
TEM analysis of cells. Cells grown as described previously were harvested by 
centrifugation at 3000 x g for 10 minutes. The cell pellet was resuspended in 2 mL 2.5% 
(w/v) glutaraldehyde in 100 mM sodium cacodylate buffer pH 7.2 (CAB) and fixed for 2 hours 
with gentle rotating (20 rpm). Cells were pelleted by centrifugation at 6000 x g for 2 minutes 
and were washed twice for 10 minutes with 100 mM CAB. Cells were post-fixed with 1% 
(w/v) osmium tetroxide in 100 mM CAB for 2 hours and subsequently washed twice with 
ddH2O. Cells were dehydrated by incubation in an ethanol gradient, 50% EtOH for 10 
minutes, 70% EtOH overnight, 90% EtOH for 10 minutes followed by three 10 minute 
washes in 100% dry EtOH. Cells were then washed twice with propylene oxide for 15 
minutes. Cell pellets were embedded by resuspension in 1 mL of a 1:1 mix of propylene 
oxide and Agar LV Resin and incubated for 30 minutes with rotation. Cell pellets were 
infiltrated twice in 100% Agar LV resin. The cell pellet was re-suspended in fresh resin and 
transferred to a 1 mL Beem embedding capsule, centrifuged for 5 minutes at 3000 x g to 
concentrate the cells to the tip of the mould and incubated for 20 hours at 60 °C to 
polymerize.  
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Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome with a diamond knife 
(diatome 45°). Sections (60 – 70 nm) were collected on un-coated 300 mesh copper grids. 
Grids were stained by incubation in 4.5% (w/v) uranyl acetate in 1% (v/v) acetic acid solution 
for 45 minutes followed by washing in a stream of ddH2O. Grids were then stained with 
Reynolds lead citrate for 7 minutes followed by washing in a stream of ddH2O. Electron 
microscopy was performed using a JEOL-1230 transmission electron microscope equipped 
with a Gatan multiscan digital camera operated at an accelerating voltage of 80 kV 
Tomography. Sections (250 nm) were cut from the existing blocks and 15nm gold fiducials 
(Aurion, TomoSol solution) were applied to both surfaces of the sections. The sections were 
imaged at 200 kV in a Tecnai 20 TEM (FEI, the Netherlands) and double tilt series images 
acquired between -62° to +69.5° (first axis) and -68° to +69.5° (second axis) with 1.5° 
(above 50°) and 2° increments (below 50°). The pixel size on the 4k by 4k FEI Eagle camera 
was 0.74nm. The resulting tomograms were reconstructed and combined using IMOD 
software40,41. The tube-like structures were modelled automatically using the AMIRA 
XTracing Extension of the AMIRA software suite, developed for automatic tracing of 
microtubules34. A cylinder template is correlated with the data to find and search for the 
centre lines of tubes.  A small cropped area was used to refine the fitting parameters as 
shown in Supplementary Movie S2 and these were then applied to the full data set. AMIRA 
software was further used for visualizing the data. 
Measurements of in vivo nanotubes. Diameter measurements of 100 nanotubes from 10 
cells were calculated in ImageJ42. Length measurements were calculated automatically 
using the XTracing extension of the AMIRA software suite. Cropping box measurements 
were removed manually from the dataset, leaving a total of 739 tubes. 
Purification of CC-Di-B-PduA*. CC-Di-B tagged PduA* was overproduced as described 
previously. Cells were harvested by centrifugation at 2683 x g. A 1 g wet cell pellet was 
resuspended in 20 mL Yeast Protein Extraction Reagent (Thermo Scientific) supplemented 
Lee et al. Engineered bacterial cytoscaffolds  22 
with Protease Inhibitor Cocktail Tablets, EDTA-Free (Sigma-Aldrich) and 500 Units 
Benzonase® Nuclease (Merck) and incubated for 3 hours at room temperature with gentle 
shaking. CC-Di-B-PduA* nanotubes were pelleted from the lysate by centrifugation for 5 
minutes at 11,300 x g, the pellet was resuspended in 2 mL of 20 mM Tris-HCl, pH 8, 
containing 20 mM NaCl. The suspension was centrifuged for 5 minutes at 11,000 x g, the 
resulting nanotube containing pellet was resuspended in 20 mM Tris-HCl, pH 8, and 
centrifuged again as above. The supernatant was removed and adjusted with a solution of 
5M NaCl to give a final concentration of 80 mM. A final centrifugation step as above was 
performed and the resulting pellet was analyzed for the presence of PduA* nanotubes. 
Analysis of purified nanotubes. TEM: Following purification, 20 µL of CC-Di-B-PduA* 
nanotubes were deposited onto formvar, carbon coated 300 mesh copper grids and 
incubated to 5 minutes. Glutaraldehyde (20 µL of 2.5 % (v/v)) in PBS was then added and 
incubated for a further 5 minutes before washing in 3 drops of 2.5 % (v/v) glutaraldehyde in 
PBS followed by 3 drops of ddH2O. Grids were stained with 2% (w/v) aqueous uranyl 
acetate and subsequently dried. Electron microscopy was performed using a JEOL-1230 
transmission electron microscope equipped with a Gatan multiscan digital camera operated 
at an accelerating voltage of 80 kV. 
AFM: Purified CC-Di-B-PduA* nanotubes (20 µL) nanotubes were deposited onto freshly 
cleaved mica surfaces and incubated for 5 minutes followed by the addition of 20 µL 2.5 % 
(v/v) glutaraldehyde in PBS. Surfaces were washed 3 times with 1 mL of ddH2O then dried 
under a gentle stream of N2. Images were acquired in air at 20 °C using a Bruker MultiMode 
8 Scaning probe microscope operating under Peak-Force tapping mode (ScanAsyst, Bruker) 
with a ScanSsyst-air probe (Bruker). Areas (10 µm x 10 µm) were scanned at a resolution of 
4096 x 4096 pixels. Bow and tilt were removed using NanoScope Analysis 1.4 (Bruker). 
Confocal imaging. Following growth and induction of protein expression 1 mL of cells was 
harvested by centrifugation at 3000 x g. The resulting cell pellet was washed 3 times in PBS 
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before incubation for 15 minutes in 2% (w/v) formaldehyde in PBS, cells were then washed a 
further 3 times in PBS. Cells (10 µL) were pipetted onto a 1.5 thickness coverslip before 
being inverted onto a drop of ProLong Gold antifade mountant (Life Technologies) on a 
glass slide Slides were incubated at room temperature in the dark for 24 hours to cure. 
Images were acquired on a Leica TCS SP8 system attached to a Leica DMi8 inverted 
microscope (Leica Microsystems). Excitation light (514 nm for mCitrine or 594 nm for 
mCherry) was provided by a white light laser with a repetition rate of 80 MHz. Images were 
acquired using a 100 x 1.4 NA oil immersion objective and fluorescence was detected 
through bandpasses of 520 – 570 nm (mCitrine detection) or 600 - 650 nm (mCherry 
detection).  
Correlative Light Electron Microscopy. Cells were harvested by centrifugation at 3000 x g 
for 5 minutes. Cells (1μL) were loaded into a 0.1 mm membrane carrier (Leica) and vitrified 
by high pressure freezing (EMPACT2 + RTS, Leica). Frozen membrane carriers were 
transferred into 1 mL of freeze substitution medium (0.2% uranyl acetate, 5% H2O, in 
acetone) and held at -90°C for 5 hours in an automated freeze substitution unit (AFS2, 
Leica) equipped with an attachment for automated reagent exchange (Freeze Substitution 
Processor, FSP, Leica) (30). Samples were warmed to -45°C at a rate of 5 °C/hour, held at -
45°C for 2 hours before washes in acetone and ethanol for 30 minutes each. Samples were 
then infiltrated with 25, 50 and 75% dilutions of Lowicryl HM20 resin for 3 hours each before 
infiltrating with 100% resin overnight, followed by a further 3 changes of resin for 2 hours 
each. UV polymerization was performed over approximately 48 hours; initially at -45°C for 16 
hours, before warming to 0°C at a slope of 5°C/hour and finally at 0°C for approximately 14 
hours.  
Following polymerization, blocks were removed from flow through containers and carriers 
were detached using liquid nitrogen and the specimen carrier detaching tool (Leica) heated 
to 40°C. Blocks were trimmed and sectioned with a 45° diamond knife using an EM UC6 
microtome (Leica). 70 and 300 nm thick sections were collected on carbon-coated pioloform 
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films on H6 copper finder grids (Agar Scientific). Grids were air dried, mounted in PBS 
between a glass slide and coverslip and imaged by light microscopy using a Leica DMI4000 
B inverted epifluorescence microscope fitted with a 63x oil immersion lens (NA 1.4). After 
imaging, the grids were washed in H2O and air dried before imaging in TEM. Image 
registration of light and electron microscopy images was performed using the eC-CLEM 
plugin in ICY43.  
Analysis of enzyme levels. Relative amounts of Pdc and Adh were quantified by western 
blot. Total cell lysate samples, adjusted to cell number were analyzed by SDS-PAGE and 
subsequently western blot analysis. Peak areas were quantified using the gel analysis tool in 
Image J. Due to the higher molecular weight band close to CC-Di-A-Adh half of this peak 
was quantified on the assumption that the peak was symmetrical. Measurements were 
repeated for each of the cultures. 
MinD colocalization . DNA encoding the c-terminal membrane-associating region of MinD 
was synthesized and cloned into the SpeI/BlpI sites of pET_CC_Di_A_Citrine_No_Stop and 
pET_C_Citrine_No_Stop. Cells were transformed as described previously and grown in LB 
media at 37 °C with shaking to an OD600 ~ 0.4, protein production was induced by addition of 
IPTG to a final concentration of 400 µM. Cultures were then incubated with shaking at 19 °C 
for 4 hours. Cells were harvested, fixed, embedded and sectioned as described previously. 
A total of 250 cells in the transverse orientation for each strain were analyzed for the 
presence and location of transverse CC-Di-B-PduA* nanotubes. Statistical analysis was 
performed in Minitab Software version 17 using a one-way ANOVA (Analysis of Variance) at 
the 99% level with posthoc analysis by Tukey’s test. 
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Data Availability Statement 
All data generated or analyzed during this study are included in this published article (and 
supplementary information files) or are available from the corresponding authors on 
reasonable request. 
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